Concepedia

Author

Kazuyuki Shimada

Jichi Medical UniversityORCID

Also Known As

K Shimada, K. SHIMADA, K. Shimada, KAZUYUKI SHIMADA, Kazuo Muroi, Kazuyuki SHIMADA, Kazuyuki Shimada, Kiyoshi Shimada, Shimada, Kazuyuki, Tait Shanafelt

578

Publications

18.2K

Citations

62

H-Index

239

Concepts

All Affiliations

Jichi Medical UniversityNagoya UniversityNagoya University HospitalAichi Cancer CenterNagoya Medical Center
KS

About

Kazuyuki Shimada is an author at Jichi Medical University specializing in medicine, immunology, and vascular biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

40

101

9K

2

Health Sciences

11

14

523

3

Natural Sciences

9

9

862

4

Engineering

4

4

146

5

Education

2

2

63

Kazuyuki Shimada

×

225

Publications

15.8K

Citations

59

H-Index

YearCitations

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

Mitsuhiro Yokoyama, Hideki Origasa, Masunori Matsuzaki,

The Lancet

2007

2.5K

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

Eriko Tateishi-Yuyama, Hiroaki Matsubara, Toyoaki Murohara,

The Lancet

2002

1.7K

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)

Yasushi Saitō, Mitsuhiro Yokoyama, Hideki Origasa,

Atherosclerosis

2008

318

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

Waleed Alduaij, Andrei Ivanov, Jamie Honeychurch,

Blood

2011

289

Target Antigen Density Governs the Efficacy of Anti–CD20-CD28-CD3 ζ Chimeric Antigen Receptor–Modified Effector CD8+ T Cells

Keisuke Watanabe, Seitaro Terakura, Anton C. Martens,

The Journal of Immunology

2014

280

Retrospective Analysis of Intravascular Large B-Cell Lymphoma Treated With Rituximab-Containing Chemotherapy As Reported by the IVL Study Group in Japan

Kazuyuki Shimada, Kosei Matsue, Kazuhito Yamamoto,

Journal of Clinical Oncology

2008

277

Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance

Junji Hiraga, Akihiro Tomita, Takumi Sugimoto,

Blood

2009

253

Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells.

Masanori Nishinaga, Takeaki Ozawa, Kazuyuki Shimada

Journal of Clinical Investigation

1993

243

Reduction in the Recurrence of Stroke by Eicosapentaenoic Acid for Hypercholesterolemic Patients

Kortaro Tanaka, Yuichi Ishikawa, Mitsuhiro Yokoyama,

Stroke

2008

212

Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.

Keiji Yamamoto, Ruri Ohki, Richard Lee,

PubMed

2001

195

Page 1